200 related articles for article (PubMed ID: 22330910)
1. Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.
Pulido D; Moussaoui M; Andreu D; Nogués MV; Torrent M; Boix E
Antimicrob Agents Chemother; 2012 May; 56(5):2378-85. PubMed ID: 22330910
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for endotoxin neutralization by the eosinophil cationic protein.
Pulido D; Garcia-Mayoral MF; Moussaoui M; Velázquez D; Torrent M; Bruix M; Boix E
FEBS J; 2016 Nov; 283(22):4176-4191. PubMed ID: 27696685
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
4. A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.
Pulido D; Prats-Ejarque G; Villalba C; Albacar M; González-López JJ; Torrent M; Moussaoui M; Boix E
Antimicrob Agents Chemother; 2016 Oct; 60(10):6313-25. PubMed ID: 27527084
[TBL] [Abstract][Full Text] [Related]
5. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
[TBL] [Abstract][Full Text] [Related]
6. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.
Torrent M; Pulido D; de la Torre BG; García-Mayoral MF; Nogués MV; Bruix M; Andreu D; Boix E
J Med Chem; 2011 Jul; 54(14):5237-44. PubMed ID: 21696142
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
Torrent M; Navarro S; Moussaoui M; Nogués MV; Boix E
Biochemistry; 2008 Mar; 47(11):3544-55. PubMed ID: 18293932
[TBL] [Abstract][Full Text] [Related]
8. Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms.
Salazar VA; Rubin J; Moussaoui M; Pulido D; Nogués MV; Venge P; Boix E
FEBS J; 2014 Dec; 281(24):5432-46. PubMed ID: 25271100
[TBL] [Abstract][Full Text] [Related]
9. Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.
Pulido D; Prats-Ejarque G; Villalba C; Albacar M; Moussaoui M; Andreu D; Volkmer R; Torrent M; Boix E
Eur J Med Chem; 2018 May; 152():590-599. PubMed ID: 29763807
[TBL] [Abstract][Full Text] [Related]
10. Structure and Interactions of A Host Defense Antimicrobial Peptide Thanatin in Lipopolysaccharide Micelles Reveal Mechanism of Bacterial Cell Agglutination.
Sinha S; Zheng L; Mu Y; Ng WJ; Bhattacharjya S
Sci Rep; 2017 Dec; 7(1):17795. PubMed ID: 29259246
[TBL] [Abstract][Full Text] [Related]
11. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
Torrent M; Badia M; Moussaoui M; Sanchez D; Nogués MV; Boix E
FEBS J; 2010 Apr; 277(7):1713-25. PubMed ID: 20180804
[TBL] [Abstract][Full Text] [Related]
13. Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation.
Torrent M; Pulido D; Nogués MV; Boix E
PLoS Pathog; 2012; 8(11):e1003005. PubMed ID: 23133388
[TBL] [Abstract][Full Text] [Related]
14. NMR Structures and Interactions of Antimicrobial Peptides with Lipopolysaccharide: Connecting Structures to Functions.
Bhattacharjya S
Curr Top Med Chem; 2016; 16(1):4-15. PubMed ID: 26139110
[TBL] [Abstract][Full Text] [Related]
15. Salt-resistant short antimicrobial peptides.
Mohanram H; Bhattacharjya S
Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911
[TBL] [Abstract][Full Text] [Related]
16. Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap.
Mohanram H; Bhattacharjya S
Antimicrob Agents Chemother; 2014; 58(4):1987-96. PubMed ID: 24419338
[TBL] [Abstract][Full Text] [Related]
17. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
Brandenburg K; Heinbockel L; Correa W; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
[TBL] [Abstract][Full Text] [Related]
18. The antipathogen activities of eosinophil cationic protein.
Boix E; Torrent M; Sánchez D; Nogués MV
Curr Pharm Biotechnol; 2008 Jun; 9(3):141-52. PubMed ID: 18673279
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of the eosinophil cationic protein antimicrobial activity.
Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
[TBL] [Abstract][Full Text] [Related]
20. Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.
Domadia PN; Bhunia A; Ramamoorthy A; Bhattacharjya S
J Am Chem Soc; 2010 Dec; 132(51):18417-28. PubMed ID: 21128620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
